Infections in very LBW infants stunt neurodevelopment and growth
In what is perhaps the largest study to date to evaluate the impact of neonatal infection on adverse outcomes in early childhood, researchers have found that neonatal infections among extremely low-birthweight (ELBW) infants are associated with serious adverse neurodevelopmental and growth outcomes in early childhood that contribute to long-term disability.
In what is perhaps the largest study to date to evaluate the impact of neonatal infection on adverse outcomes in early childhood, researchers have found that neonatal infections among extremely low-birthweight (ELBW) infants are associated with serious adverse neurodevelopmental and growth outcomes in early childhood that contribute to long-term disability.
The prospective cohort study included over 6,000 infants weighing 401 to 1,000 g at birth. Sixty-five percent of the ELBW survivors had at least one infection during their postbirth hospital stay: 1,538 developed clinical infection alone; 1,922 developed sepsis alone; 279 developed sepsis and necrotizing enterocolitis (NEC); and 193 developed meningitis with or without sepsis.
Compared with uninfected infants, those who were in any of the four infection groups were significantly more likely to develop cerebral palsy (range of significant odds ratio [OR], 1.4-1.7), low Bayley Scales of Infant Development II scores on the mental development index (OR, 1.3-1.6) and psychomotor development index (OR, 1.5-2.4), and vision impairment (OR, 1.3-2.2). Infants with sepsis and NEC were at highest risk for adverse outcomes.
The benefits of concurrent fetal and maternal heart rate monitoring
April 15th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Read More
How vitamin C intake in pregnant smokers impacts offspring airway function trajectory
April 12th 2024Investigating the impact of prenatal vitamin C supplementation on lung function and wheeze occurrence in offspring of pregnant smokers, revealing insights into mitigating respiratory risks.
Read More
NAID report shows maternal COVID-19 vaccination protects newborns
April 4th 2024New research led by the National Institute of Allergy and Infectious Diseases reveals sustained antibody levels in infants born to vaccinated mothers, underscoring the importance of maternal vaccination in safeguarding newborns against COVID-19.
Read More
FDA grants FTD to nipocalimab for treating FNAIT
March 26th 2024The FDA's Fast Track Designation for nipocalimab marks a significant step in addressing fetal neonatal alloimmune thrombocytopenia risk in pregnant patients, potentially revolutionizing treatment for this severe condition with unmet medical needs.
Read More
